PMID: 9418766Jan 7, 1998Paper

Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview

Journal of the American Academy of Dermatology
P D DonckerA Heremans

Abstract

Itraconazole is a broad-spectrum antifungal agent that has been used to treat dermatomycosis and onychomycosis using continuous therapy. More recently the drug has been used as pulse dosing. Our purpose was to review the studies in which itraconazole pulse therapy (PT) has been administered in the management of dermatomycoses. For tinea pedis and manuum, the recommended dosage is itraconazole 200 mg twice daily for 1 week (n = 220). A clinical response and mycologic cure rate of 90% +/- 4% and 76% +/- 6%, respectively, has been obtained. For tinea corporis/cruris, itraconazole 200 mg/day for 1 week (n = 354) resulted in a clinical response and mycologic cure rate of 90% +/- 4% and 77% +/- 6%, respectively. When three pulses of itraconazole are used to treat toenail onychomycosis (n = 1389), the clinical cure rate, clinical response, and mycologic cure rate at follow-up 12 months after the start of therapy were 58% +/- 10%, 82% +/- 3%, and 77% +/- 5%, respectively. With two pulses for onychomycosis of the fingernails, the clinical cure rate, clinical response, and mycologic cure rate at follow-up, 9 months after the start of therapy, were 78% +/- 10%, 89% +/- 6%, and 87% +/- 8%, respectively. Itraconazole PT is effective and saf...Continue Reading

References

May 1, 1992·Journal of the American Academy of Dermatology·M WillemsenD Roseeuw
Mar 1, 1990·Clinical and Experimental Dermatology·D RoseeuwJ Van Cutsem
Sep 1, 1990·Journal of the American Academy of Dermatology·J Delescluse
Sep 1, 1990·Journal of the American Academy of Dermatology·A Saul, A Bonifaz
Sep 1, 1990·Journal of the American Academy of Dermatology·R J HayG Midgely
Feb 1, 1988·Journal of the American Academy of Dermatology·G CauwenberghK Haeverans
Jan 1, 1987·Annali Dell'Istituto Superiore Di Sanità·E PanconesiG M Palleschi
Sep 1, 1988·The British Journal of Dermatology·R J HayG Midgely
Jun 1, 1986·The British Journal of Dermatology·J DelescluseH Degreef
Jan 1, 1987·Reviews of Infectious Diseases·H DegreefL Verhoeve
Jan 1, 1987·Reviews of Infectious Diseases·S T Nuijten, J L Schuller
Jan 1, 1987·Reviews of Infectious Diseases·A del Palacio HernanzA Rodríguez-Noriega Belaustegui
Jan 1, 1987·Reviews of Infectious Diseases·R A Estrada
Jan 1, 1987·Reviews of Infectious Diseases·G CauwenberghV Schuermans
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Jun 1, 1994·Journal of the American Academy of Dermatology·A K GuptaN H Shear
Feb 1, 1995·International Journal of Dermatology·J Decroix
Mar 1, 1995·Journal of the American Academy of Dermatology·G E PiérardP De Doncker
Jan 1, 1994·Dermatology : International Journal for Clinical and Investigative Dermatology·D ParentM Heenen
Aug 1, 1994·Journal of the American Academy of Dermatology·D M PariserT L Ray
Jul 1, 1993·Clinical and Experimental Dermatology·A KatsambasJ Stratigos
Apr 1, 1996·The Journal of Family Practice·G N Smith

❮ Previous
Next ❯

Citations

Nov 30, 2000·Current Infectious Disease Reports· Del Rosso JQ
Oct 12, 2000·Clinics in Dermatology·R A Johnson
Oct 9, 1999·International Journal of Dermatology·J E ArreseG E Piérard
Oct 9, 1999·International Journal of Dermatology·A K Gupta, J Lambert
Jan 29, 2000·International Journal of Dermatology·S Jain, V N Sehgal
Aug 12, 2000·International Journal of Dermatology·A K GuptaH Degreef
Aug 10, 2001·Journal of the European Academy of Dermatology and Venereology : JEADV·A K GuptaE Haneke
Aug 12, 2000·Drugs & Aging·A K Gupta
Jul 27, 2011·Medical Mycology Journal·Takashi Harada
Jul 1, 1998·International Journal of Dermatology·S K NoltingJ R Lambert
Apr 14, 2007·Dermatologic Clinics·Alexandra Y ZhangBoni E Elewski
Feb 20, 2007·Journal of the American Academy of Dermatology·Richard K ScherBoni E Elewski
Nov 12, 2005·Skinmed·Aditya K GuptaElizabeth A Cooper
Feb 21, 2006·Clinical and Experimental Dermatology·R Ungpakorn, S Reangchainam
Apr 17, 2008·International Journal of Dermatology·Leslie A Field, Brian B Adams
Sep 6, 2003·Dermatologic Clinics·Aditya K GuptaRaza Aly
May 16, 2008·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Hans Christian Korting, Claudia Schöllmann
Mar 16, 2001·Expert Opinion on Pharmacotherapy·G E PiérardC Piérard-Franchimont
Jun 7, 2005·Expert Opinion on Pharmacotherapy·Robert BaranGerald E Piérard
Jul 12, 2002·Acta Microbiologica Et Immunologica Hungarica·Nóra Erös, Zsuzsánna Károlyi
Mar 11, 1998·Lancet·A K Gupta, R K Scher
Aug 19, 2005·Expert Review of Anti-infective Therapy·Adolfo C Fernandez-ObregonCarolyn Willis
Oct 16, 2004·Expert Review of Anti-infective Therapy·R Caputo
Jan 27, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·A K Gupta, N H Shear
Apr 7, 2019·Expert Review of Clinical Pharmacology·Kabir SardanaAastha Gupta
May 17, 2002·Journal of the American Podiatric Medical Association·Aditya K Gupta
May 15, 2008·Mycopathologia·Aditya K Gupta, Elizabeth A Cooper
Jan 23, 2009·The Journal of Dermatological Treatment·Ranthilaka R RanawakaRamya W Ragunathan
Jun 13, 2006·The Journal of Dermatological Treatment·Shemer AvnerTrau Henri
Nov 13, 2001·American Journal of Clinical Dermatology·B E Elewski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.